In response to rumours reported in the press, the Company confirms that it is currently studying various targeted disposal options as part of the implementation of its refinancing plan, as announced on 14 November
Clariane (CLARIA.PA - ISIN FR0010386334): in response to rumours reported in the press, the Company confirms that it is currently studying various targeted disposal options as part of the implementation of its refinancing plan, as announced on 14 November 2023, aimed at improving cash flow generation and controlling debt levels.
In this context, the company confirms that it has held an information meeting with the members of the CSEC, following current French regulations, on the possible sale of its Hospitalisation à Domicile and Services de Soins Infirmiers à Domicile (HAD/SSIAD) business in France.
The Group currently owns 8 specialised HAD homes and 3 SSIAD agencies in France, employing 309 people (full-time equivalent). In 2023, this business generated sales of just over €46 million.
As of the date of this press release, the Group has not received any firm offer to acquire this business.
In this context, the Company will make no further comment on this eventuality and will communicate in due course any element relating to its refinancing plan, in strict compliance with the regulations in force.
